tag:blogger.com,1999:blog-36634196.post3637593983626905188..comments2023-10-09T11:33:37.853-05:00Comments on The IN VIVO Blog: Dollens: Reimbursement Uncertainty May Slow InnovationChris Morrisonhttp://www.blogger.com/profile/04075266444951558159noreply@blogger.comBlogger1125tag:blogger.com,1999:blog-36634196.post-61838357888063660122007-10-04T14:17:00.000-05:002007-10-04T14:17:00.000-05:00At the 2007 Medical Innovation Summit at the Cleve...At the 2007 Medical Innovation Summit at the Cleveland Clinic, the audience (some 600 registered) was asked if changes in reimbursment, healthcare policy et al. would negatively affect innovation. The surprise answer in this more medical device heavy audience was the 60% percent denied, that lower reimbursement would hamper innovation.<BR/><BR/>Fundamentally that answer makes more sense than the industry tagline of less reimbursement leading to less innovation. Why? All other industries are innovating to have better products for lower (aka more competitive prices), whereas only the healthcare industry believes that innovation equates ever more increasing spending. In fact, the IT industry (the demise of Digital as for instance) has demonstrated that industry cycles lead to cheaper products for more people. That is also innovation. For more: heed Christenson's "The Innovators Dilema".Anonymousnoreply@blogger.com